HPV-related cancer

The research group focuses on HPV-related cancers, with particular emphasis on developing and evaluating methods for prevention, screening, diagnosis, and clinical follow-up using precision medicine approaches. The research also includes health economic evaluations of diagnostic methods and preventive interventions to assess their cost-effectiveness and benefits for patients and society. Key research areas include diagnostic accuracy, participation and adherence in cervical cancer screening, and biomarkers in cervical, vulvar, vaginal, and penile cancers. By improving opportunities for prevention, early detection, personalised diagnosis, and clinical follow-up, the research aims to reduce the morbidity and mortality associated with HPV-related cancers, improve patients’ quality of life, and contribute to more equitable and resource-efficient cancer care. The health economic evaluations provide evidence to support the efficient allocation of healthcare resources to maximise health benefits for both individuals and society.